Unichem Laboratories is currently trading at Rs 184.15, up by 4.30 points or 2.39% from its previous closing of Rs 179.85 on the BSE.
The scrip opened at Rs 182.55 and has touched a high and low of Rs 186.75 and Rs. 180.00 respectively. So far 28671 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 203.35 on 25-Sep-2012 and a 52 week low of Rs 101.15 on 13-Dec-2011.
Last one week high and low of the scrip stood at Rs 184.00 and Rs 171.25 respectively. The current market cap of the company is Rs 2191.98 crore.
The promoters holding in the company stood at 49.53% while Institutions and Non-Institutions held 13.95% and 36.52% respectively.
Unichem Laboratories has received ANDA approval from the United States Food and Administration (USFDA) for Tizanidine Tablets. Tizanidine tablets USP 2mg and 4mg are therapeutically equivalent to ZANAFlEX tablets 2mg and 4mg from Acorda Therapeutics. Tizanidine tablets belong to a group of medicines called skeletal muscle relaxants. Tizanidine tablets is used to help relieve, although not cure, muscle spasms caused by medical conditions such as multiple sclerosis or injuries to the brain or spine.
Further, the product will be commercialized from Unichem’s Goa plant. Further, active pharmaceutical ingredient i.e., Tizanidine Hydrochloride used for this ANDA is also made in-house at Roha plant.
Currently, there are 9 generic approvals, while only 3 companies are dominating the market. The current market size is $70 million growing at 5% in value terms and 10% in volume.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1861.70 |
Dr. Reddys Lab | 1389.35 |
Cipla | 1506.15 |
Lupin | 2228.00 |
Zydus Lifesciences | 972.70 |
View more.. |